{"filing":{"accession_number":"0001213900-26-075313","cik":"0001986247","ticker":"BYAH","company_name":"Park Ha Biological Technology Co., Ltd.","form":"6-K","filing_date":"2026-07-06","report_date":null,"primary_document":"ea0297048-6k_park.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1986247/000121390026075313/ea0297048-6k_park.htm"},"events":[{"id":16191,"run_id":14450,"accession_number":"0001213900-26-075313","anchor_item_number":"EX-99.1","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.8,"summary":"Park Ha Biological Technology held shareholder meetings on July 13, 2026, to vote on material governance and capital structure proposals including a massive increase in authorized share capital from 3 billion to 300 billion shares, authorization for the Board to effect share consolidations (2-for-1 to 5,000-for-1 ratio) and subdivisions (2-for-1 to 100-for-1 ratio), and an increase in Class B voting rights from 20 to 100 votes per share. These proposals would materially affect shareholder interests through potential dilution and significant changes to voting power and control dynamics.","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06","form":"6-K","submitted_at":null,"items":[{"id":14217,"accession_number":"0001213900-26-075313","item_number":"EX-99.1","item_title":"ea029704801ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This is a notice of shareholder meetings (Extraordinary General Meeting and Class A Meeting) scheduled for July 13, 2026, soliciting proxies and written resolutions on material proposals including: (1) increase in authorized share capital from 3 billion to 300 billion shares; (2) authorization for board to effect share consolidations (2-for-1 to 5,000-for-1 ratio); (3) authorization for board to effect share subdivisions (2-for-1 to 100-for-1 ratio); and (4) increase in Class B voting rights from 20 to 100 votes per share. While technically a notice *before* the vote rather than results *after* the vote, the substance is a shareholder vote on material governance and capital structure matters that would materially affect investor interests through potential massive share dilution and voting rights changes.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14218,"accession_number":"0001213900-26-075313","item_number":"EX-99.2","item_title":"ea029704801ex99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a proxy statement for an Extraordinary General Meeting scheduled for July 13, 2026, soliciting shareholder votes on four governance proposals: (1) a massive increase in authorized share capital from US$3 billion to US$300 billion shares, (2) authorization for the Board to consolidate shares at a 2-for-1 to 5,000-for-1 ratio, (3) authorization for share subdivisions at a 2-for-1 to 100-for-1 ratio, and (4) adoption of amended and restated memorandum and articles of association. While these are governance matters requiring shareholder approval, the scale of the authorized capital increase and the broad discretionary powers granted to the Board regarding share consolidation and subdivision would materially affect shareholders' interests and voting power, making this material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14219,"accession_number":"0001213900-26-075313","item_number":"EX-99.3","item_title":"ea029704801ex99-3.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a proxy form for a Class A Meeting scheduled for July 13, 2026, soliciting shareholder votes on a special resolution to increase voting rights of Class B Ordinary Shares from 20 to 100 votes per share. While this is technically a proxy solicitation document rather than a vote result, it discloses a material governance matter—a significant increase in Class B voting power—that would materially affect the capital structure and control dynamics of the company. The proposal itself (increasing Class B voting rights by 5x) is material to investors assessing voting power and control.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"","ticker":null,"filing_date":""},{"id":14220,"accession_number":"0001213900-26-075313","item_number":"EX-99.4","item_title":"ea029704801ex99-4.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a written resolution by the sole Class B shareholder approving a material variation of Class B share voting rights—increasing votes per share from 20 to 100. This is a governance event involving shareholder approval of a fundamental change to share class rights and capital structure. While not a standard named governance type (exec appointment, compensation, etc.), it is clearly material to investors as it materially alters voting power and control dynamics, and is properly classified as governance_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":16192,"run_id":14450,"accession_number":"0001213900-26-075313","anchor_item_number":"EX-99.5","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.92,"summary":"Park Ha Biological Technology adopted an amended and restated memorandum and articles of association establishing the company's constitutional framework, including share capital structure with Class A and Class B ordinary shares with differential voting rights and related share issuance, redemption, and transfer provisions.","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06","form":"6-K","submitted_at":null,"items":[{"id":14221,"accession_number":"0001213900-26-075313","item_number":"EX-99.5","item_title":"ea029704801ex99-5.htm","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.92,"reasoning":"This exhibit is the form of amended and restated memorandum and articles of association for Park Ha Biological Technology Co., Ltd., adopted pursuant to special shareholder resolutions. It is a governance document establishing the company's constitutional framework, including share capital structure (Class A and Class B ordinary shares with differential voting rights), share issuance, redemption, and transfer provisions. While governance-related, this is a routine corporate constitutional amendment rather than a discrete material event such as an executive appointment, departure, or material transaction. The document itself is administrative in nature and does not disclose a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14217,"accession_number":"0001213900-26-075313","item_number":"EX-99.1","item_title":"ea029704801ex99-1.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This is a notice of shareholder meetings (Extraordinary General Meeting and Class A Meeting) scheduled for July 13, 2026, soliciting proxies and written resolutions on material proposals including: (1) increase in authorized share capital from 3 billion to 300 billion shares; (2) authorization for board to effect share consolidations (2-for-1 to 5,000-for-1 ratio); (3) authorization for board to effect share subdivisions (2-for-1 to 100-for-1 ratio); and (4) increase in Class B voting rights from 20 to 100 votes per share. While technically a notice *before* the vote rather than results *after* the vote, the substance is a shareholder vote on material governance and capital structure matters that would materially affect investor interests through potential massive share dilution and voting rights changes.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06"},{"id":14218,"accession_number":"0001213900-26-075313","item_number":"EX-99.2","item_title":"ea029704801ex99-2.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a proxy statement for an Extraordinary General Meeting scheduled for July 13, 2026, soliciting shareholder votes on four governance proposals: (1) a massive increase in authorized share capital from US$3 billion to US$300 billion shares, (2) authorization for the Board to consolidate shares at a 2-for-1 to 5,000-for-1 ratio, (3) authorization for share subdivisions at a 2-for-1 to 100-for-1 ratio, and (4) adoption of amended and restated memorandum and articles of association. While these are governance matters requiring shareholder approval, the scale of the authorized capital increase and the broad discretionary powers granted to the Board regarding share consolidation and subdivision would materially affect shareholders' interests and voting power, making this material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06"},{"id":14219,"accession_number":"0001213900-26-075313","item_number":"EX-99.3","item_title":"ea029704801ex99-3.htm","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a proxy form for a Class A Meeting scheduled for July 13, 2026, soliciting shareholder votes on a special resolution to increase voting rights of Class B Ordinary Shares from 20 to 100 votes per share. While this is technically a proxy solicitation document rather than a vote result, it discloses a material governance matter—a significant increase in Class B voting power—that would materially affect the capital structure and control dynamics of the company. The proposal itself (increasing Class B voting rights by 5x) is material to investors assessing voting power and control.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06"},{"id":14220,"accession_number":"0001213900-26-075313","item_number":"EX-99.4","item_title":"ea029704801ex99-4.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This exhibit is a written resolution by the sole Class B shareholder approving a material variation of Class B share voting rights—increasing votes per share from 20 to 100. This is a governance event involving shareholder approval of a fundamental change to share class rights and capital structure. While not a standard named governance type (exec appointment, compensation, etc.), it is clearly material to investors as it materially alters voting power and control dynamics, and is properly classified as governance_other.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06"},{"id":14221,"accession_number":"0001213900-26-075313","item_number":"EX-99.5","item_title":"ea029704801ex99-5.htm","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.92,"reasoning":"This exhibit is the form of amended and restated memorandum and articles of association for Park Ha Biological Technology Co., Ltd., adopted pursuant to special shareholder resolutions. It is a governance document establishing the company's constitutional framework, including share capital structure (Class A and Class B ordinary shares with differential voting rights), share issuance, redemption, and transfer provisions. While governance-related, this is a routine corporate constitutional amendment rather than a discrete material event such as an executive appointment, departure, or material transaction. The document itself is administrative in nature and does not disclose a material event affecting investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-06T15:43:54.408490+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-07-06"}]}